| Name |
Tardyferon 80 mg tablete s produljenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-374611068 |
| Active Substance |
željezov(II) sulfat, suhi |
| Composition |
jedna tableta s produljenim oslobađanjem sadrži 247,25 mg suhog željezovog(II) sulfata, što odgovara 80 mg željeza |
| Pharmaceutical Form |
Tableta s produljenim oslobađanjem |
| Manufacturer |
Pierre Fabre Medicament Production, Gien, Francuska |
| Marketing Authorisation Holder |
Pierre Fabre Medicament, Les Cauquillous, Lavaur, Francuska |
| Marketing Authorisation Date |
25.05.2022 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/22-02/23 |
| Registration Number |
381-12-01/70-22-03 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
B03AA07 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
